Panion & BF Biotech Inc Market Cap ($131.42 Million)
Market Cap & Net Worth: Panion & BF Biotech Inc (1760)
Panion & BF Biotech Inc market cap. Panion & BF Biotech Inc (TW:1760) has a market capitalization of $131.42 Million (NT$4.17 Billion) as of November 4, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #17959 globally and #946 in its home market, demonstrating a -5.90% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Panion & BF Biotech Inc's stock price NT$48.65 by its total outstanding shares 85739000 (85.74 Million). Also see Panion & BF Biotech Inc (1760) cash flow conversion for how efficiently the company converts equity into cash flow.
Panion & BF Biotech Inc Market Cap History (2015–2026)
Panion & BF Biotech Inc market cap history from 2015 to 2026. Data shows change from $614.90 Million to $131.42 Million (-13.03% CAGR). Check latest Panion & BF Biotech Inc stock price today for real-time trading data and today's change.
Panion & BF Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Panion & BF Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 1760 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.11x
Panion & BF Biotech Inc's market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.78x
Panion & BF Biotech Inc's market cap is 1.78 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $614.90 Million | $1.21 Billion | $73.00 Million | 0.51x | 8.42x |
| 2016 | $161.47 Million | $1.05 Billion | $89.72 Million | 0.15x | 1.80x |
| 2017 | $178.82 Million | $1.21 Billion | $90.54 Million | 0.15x | 1.98x |
| 2018 | $204.52 Million | $1.41 Billion | $159.17 Million | 0.15x | 1.28x |
| 2019 | $214.31 Million | $1.57 Billion | $161.33 Million | 0.14x | 1.33x |
| 2020 | $215.29 Million | $1.57 Billion | $27.90 Million | 0.14x | 7.72x |
| 2021 | $194.31 Million | $1.90 Billion | $104.40 Million | 0.10x | 1.86x |
| 2022 | $468.95 Million | $2.40 Billion | $182.34 Million | 0.20x | 2.57x |
| 2023 | $297.93 Million | $1.88 Billion | $77.22 Million | 0.16x | 3.86x |
| 2024 | $221.77 Million | $2.03 Billion | $124.52 Million | 0.11x | 1.78x |
Competitor Companies of 1760 by Market Capitalization
Companies near Panion & BF Biotech Inc in the global market cap rankings as of November 4, 2026. Also see Panion & BF Biotech Inc (1760) total assets for a full breakdown of the balance sheet.
Key companies related to Panion & BF Biotech Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Panion & BF Biotech Inc (2015–2026)
Market capitalization of Panion & BF Biotech Inc from 2015 to today. Between 2015 and today, Panion & BF Biotech Inc's market cap moved from $614.90 Million to $ 131.42 Million, with a yearly change of -13.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$131.42 Million | -22.78% |
| 2025 | NT$170.18 Million | -23.26% |
| 2024 | NT$221.77 Million | -25.56% |
| 2023 | NT$297.93 Million | -36.47% |
| 2022 | NT$468.95 Million | +141.34% |
| 2021 | NT$194.31 Million | -9.75% |
| 2020 | NT$215.29 Million | +0.46% |
| 2019 | NT$214.31 Million | +4.79% |
| 2018 | NT$204.52 Million | +14.37% |
| 2017 | NT$178.82 Million | +10.74% |
| 2016 | NT$161.47 Million | -73.74% |
| 2015 | NT$614.90 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Panion & BF Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $131.42 Million USD |
| MoneyControl | $131.42 Million USD |
| MarketWatch | $131.42 Million USD |
| marketcap.company | $131.42 Million USD |
| Reuters | $131.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Panion & BF Biotech Inc
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment,… Read more